Michael J. Berendt

Michael J. Berendt is a declared insider at 2 companies (board member); the most frequent names are Waters Corp /DE/ and Retension Pharmaceuticals, Inc. We count 6 filings; the first trade dates from 4 January 2016 and the latest from 13 October 2026.

No open-market purchase appears, only 3 sales worth €1.9M. Besides market trades, the filings include 1 share grant.

On 13 October 2026 came the latest disclosure, a transaction in Retension Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.